menu

A Pathologist’s Perspective: The Role of Biomarker Testing in Metastatic Colorectal Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A Pathologist’s Perspective: The Role of Biomarker Testing in Metastatic Colorectal Cancer

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

A pathologist discusses the role of the biomarker report in managing metastatic colorectal cancer.

  • Overview

    Pathologist Fernando Uriel Garcia, MD provides his perspective on the importance of the biomarkers in determining patient prognosis and potential implications depending on a patient's biomarker status.

     © 2021 Pfizer Inc. All rights reserved. PP-BCE-USA-0289 April 2021

Programs 9/21/21